mantle cell lymphoma

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  

mantle cell lymphoma
Nov 21, 2024, 09:55 | Blog
New Hope for Mantle Cell Lymphoma Patients - The Babak Lab
The Babak Lab shared a post on LinkedIn: “FDA Approval Alert: New Hope for Mantle…
Oct 19, 2024, 11:24 | Blog
That’s a wrap on day 2 of Lymphoma, Leukemia & Myeloma Congress
Lymphoma, Leukemia & Myeloma Congress posted the following on X: “That’s a wrap on day…
Aug 25, 2024, 17:04 | Blog
Rahul Gosain: Current SoC/landscape for Follicular and Mantle Cell Lymphoma with Pallawi Torka
Rahul Gosain shared on LinkedIn: “Hematology: with Pallawi Torka we discuss the current SoC/landscape for…
Aug 14, 2024, 14:08 | Insight
Michael Wang: Phenotype- and target-driven discovery are necessary for finding cures
Michael Wang shared on X a recent paper by Zhenyi Wang et al. titled "Innovating…
Jul 28, 2024, 14:02 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Patrick Hwu
We are excited to introduce Dr. Patrick Hwu, a leading expert in cancer immunotherapy, as…
Jul 21, 2024, 12:19 | Blog
Oncoinfluencers to Follow on Social Media: Dr. Michael Wang
At OncoDaily, we are excited to highlight Dr. Michael Wang, a prominent researcher and clinician…
Jul 13, 2024, 21:06 | Insight
Michael Wang: CDK9 is a promising target in MCL
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jul 1, 2024, 02:17 | Opinion
Michael Wang: Excellent review of the actions and complex regulation of p53
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation…
Jun 29, 2024, 16:57 | Insight
MD Anderson Research Highlights: EHA 2024 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in…
Jun 20, 2024, 10:10 | Insight
Date of improved response rates in mantle cell lymphoma patients
MD Anderson Cancer Center shared on LinkedIn: "Adding the BTK inhibitor acalabrutinib to chemoimmunotherapy shows…
Jun 17, 2024, 17:03 | Blog
Michael Wang: I presented the data from ECHO trial
Michael Wang, Professor in the Department of Lymphoma/Myeloma and in the Department of Stem Cell…
Apr 15, 2024, 16:12 | Insight
Michael Wang: Our Phase I TRANSCEND trial demonstrated that Liso-cel results in consistently high objective response rates
Michael Wang, Professor in the Department of Lymphoma/Myeloma and the Department of Stem Cell Transplantation and…
Mar 31, 2024, 23:07 | Blog
Michael Wang: To my philanthropic donors, I am grateful for your support to further our attack on mantle cell lymphoma
Michael Wang, Professor in the Department of Lymphoma and Myeloma at MD Anderson Cancer Center,…
Jan 3, 2024, 18:41 | Insight
Julie Vose: The long awaited publication from the NAMCL Project
Julie Vose shared a post on X/Twitter: ''Finally! The long awaited publication from the NAMCL Project!…
Dec 27, 2023, 13:13 | Insight
Charles Gaulin: Safety of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma
Charles Gaulin, Lymphoma/Myeloma Fellow at MD Anderson Cancer Center, shared on LinkedIn: "At ASH23, we presented…
All: 15 Posts: 1 - 100
Special Coverage